Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Coffee and liver health.

Morisco F, Lembo V, Mazzone G, Camera S, Caporaso N.

J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S87-90. doi: 10.1097/MCG.0000000000000240. Review.

PMID:
25291138
2.

[Coffee as hepatoprotective factor].

Szántová M, Ďurkovičová Z.

Vnitr Lek. Winter 2016;62(12):990-997. Review. Czech.

PMID:
28139128
3.

Coffee and liver diseases.

Muriel P, Arauz J.

Fitoterapia. 2010 Jul;81(5):297-305. doi: 10.1016/j.fitote.2009.10.003. Epub 2009 Oct 13. Review.

PMID:
19825397
4.

Coffee and the liver: a potential treatment for liver disease?

Masterton GS, Hayes PC.

Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1277-83. doi: 10.1097/MEG.0b013e32833cca96. Review.

PMID:
20802342
5.

Coffee, liver enzymes, cirrhosis and liver cancer.

La Vecchia C.

J Hepatol. 2005 Apr;42(4):444-6. Epub 2005 Jan 21. Review. No abstract available.

PMID:
15763323
6.

[Coffee can be beneficial for patients with liver diseases].

Kjærgaard M, Thiele M, Krag A.

Ugeskr Laeger. 2014 Oct 20;176(43). pii: V04140209. Review. Danish.

PMID:
25353679
7.

Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?

Chen S, Teoh NC, Chitturi S, Farrell GC.

J Gastroenterol Hepatol. 2014 Mar;29(3):435-41. doi: 10.1111/jgh.12422. Review.

PMID:
24199670
8.

Coffee and health: a review of recent human research.

Higdon JV, Frei B.

Crit Rev Food Sci Nutr. 2006;46(2):101-23. Review.

PMID:
16507475
9.

Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.

Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C.

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1413-1421.e1. doi: 10.1016/j.cgh.2013.04.039. Epub 2013 May 6.

PMID:
23660416
10.

Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.

Vitaglione P, Morisco F, Mazzone G, Amoruso DC, Ribecco MT, Romano A, Fogliano V, Caporaso N, D'Argenio G.

Hepatology. 2010 Nov;52(5):1652-61. doi: 10.1002/hep.23902.

PMID:
21038411
11.

Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.

Inoue M, Yoshimi I, Sobue T, Tsugane S; JPHC Study Group.

J Natl Cancer Inst. 2005 Feb 16;97(4):293-300.

PMID:
15713964
12.

Impact of coffee on liver diseases: a systematic review.

Saab S, Mallam D, Cox GA 2nd, Tong MJ.

Liver Int. 2014 Apr;34(4):495-504. doi: 10.1111/liv.12304. Epub 2013 Sep 15. Review.

PMID:
24102757
13.

Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies.

Bravi F, Tavani A, Bosetti C, Boffetta P, La Vecchia C.

Eur J Cancer Prev. 2017 Sep;26(5):368-377. doi: 10.1097/CEJ.0000000000000252. Review.

PMID:
27111112
14.

Coffee consumption and risk of liver cancer: a meta-analysis.

Larsson SC, Wolk A.

Gastroenterology. 2007 May;132(5):1740-5. Epub 2007 Mar 24.

PMID:
17484871
15.

Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.

Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, Yuan JM.

Cancer Causes Control. 2011 Mar;22(3):503-10. doi: 10.1007/s10552-010-9725-0. Epub 2011 Jan 22.

16.

Review article: possible beneficial effects of coffee on liver disease and function.

Cadden IS, Partovi N, Yoshida EM.

Aliment Pharmacol Ther. 2007 Jul 1;26(1):1-8. Review.

17.

Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study.

Leung WW, Ho SC, Chan HL, Wong V, Yeo W, Mok TS.

J Epidemiol Community Health. 2011 Jun;65(6):556-8. doi: 10.1136/jech.2009.104125. Epub 2010 Aug 6.

PMID:
20693491
18.

Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.

Jazag A, Puntsagdulam N, Chinburen J.

Korean J Intern Med. 2012 Jun;27(2):121-7. doi: 10.3904/kjim.2012.27.2.121. Epub 2012 May 31. Review.

19.
20.

Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice.

Watanabe S, Takahashi T, Ogawa H, Uehara H, Tsunematsu T, Baba H, Morimoto Y, Tsuneyama K.

Metab Syndr Relat Disord. 2017 May;15(4):170-177. doi: 10.1089/met.2016.0114. Epub 2017 Mar 30.

PMID:
28358620

Supplemental Content

Support Center